Anna Schuh
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research 69
- Hemoglobinopathies and Related Disorders 19
- Hematology top 1%
- Iron Metabolism and Disorders 15
- Chronic Myeloid Leukemia Treatments 11
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 52
- Immunology top 5%
- Immunodeficiency and Autoimmune Disorders 24
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 24
-
- Acute Lymphoblastic Leukemia research 11
- Co-authors
- Peter HillmenSarah WordsworthShirley HendersonJames BuchananHélène DreauJenny C. TaylorToby A. EyreRuth Clifford
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Anna Schuh
142 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 126
- Genetics 1.8k
- Hematology 792
- Pathology and Forensic Medicine 1.3k
- Immunology 677
- Cancer Research 377
Countries citing papers authored by Anna Schuh
This map shows the geographic impact of Anna Schuh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Schuh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Schuh more than expected).
Fields of papers citing papers by Anna Schuh
This network shows the impact of papers produced by Anna Schuh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Schuh. The network helps show where Anna Schuh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna Schuh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2020 | 6 | |
| 5 | 2020 | 10 | |
| 6 | 2019 | 144 | |
| 7 | 2019 | 140 | |
| 8 | 2019 | 19 | |
| 9 | 2019 | 180 | |
| 10 | 2018 | 7 | |
| 11 | 2017 | 25 | |
| 12 | 2017 | 0 | |
| 13 | The initial report of the bloodwise tap clarity study combining ibrutinib and venetoclax in relapsed, refractory Cll shows acceptable safety and promising early indications of efficacy. | 2017 | 4 |
| 14 | 2016 | 14 | |
| 15 | Idelalisib in Combination with Bendamustine/rituximab Improves Overall Survival in Patients with Relapsed/refractory Cll: Interim Results of a Phase 3 Randomized Double-Blind Placebo-Controlled Study | 2016 | 2 |
| 16 | Rituximab in combination with bendamustine or chlorambucil for the treatment of chronic lymphocytic leukemia: primary results from the randomised phase IIIb MABLE study | 2015 | 10 |
| 17 | 2013 | 58 | |
| 18 | MUTATIONS IN SETBP1 GENE ARE RECURRENT IN MYELODYSPLASTIC SYNDROMES AND OFTEN COEXIST WITH CYTOGENETIC MARKERS ASSOCIATED WITH POOR PROGNOSIS | 2013 | 0 |
| 19 | GERMLINE ACTIVATING JAK2-MUTATION IN A FAMILY WITH HEREDITARY THROMBOCYTOSIS | 2012 | 1 |
| 20 | IDENTIFICATION OF NOVEL RECURRENT COPY NUMBER VARIATIONS BY HIGH RESOLUTION COMPARATIVE GENOME HYBRIDISATION | 2009 | 1 |
About Anna Schuh
Anna Schuh is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Cancer Research and Immunology, having authored 152 papers that have together received 3.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (69 papers), Lymphoma Diagnosis and Treatment (52 papers), Cancer Genomics and Diagnostics (24 papers), Immunodeficiency and Autoimmune Disorders (24 papers), Hemoglobinopathies and Related Disorders (19 papers), Iron Metabolism and Disorders (15 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Acute Lymphoblastic Leukemia research (11 papers). The work is most often cited by research in Genetics (1.8k citations), Hematology (792 citations), Pathology and Forensic Medicine (1.3k citations), Immunology (677 citations) and Cancer Research (377 citations). Anna Schuh has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Peter Hillmen, Sarah Wordsworth, Shirley Henderson, James Buchanan, Hélène Dreau, Jenny C. Taylor, Toby A. Eyre, Ruth Clifford, Adele Timbs and Andrew R. Pettitt. Their work appears in journals such as Blood, British Journal of Haematology, Haematologica, Journal of Clinical Oncology and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.